TITLE

…but it won't rush into purchases

AUTHOR(S)
Jagger, Anna
PUB. DATE
June 2007
SOURCE
ICIS Chemical Business;6/18/2007, Vol. 2 Issue 71, p44
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article reports on the decision of Akzo Nobel not to rush into purchases following its divestment of Organon BioSciences (OBS), according to CEO Hans Wijers. Wijers states that potential acquisition targets would need to fit strategically with the existing portfolio and create value for shareholders. Akzo Nobel board member Leif Darner said that while the company is mainly targeting organic investments at emerging markets, acquisitions could be in different regions.
ACCESSION #
25890852

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics